Literature DB >> 8694843

In vitro inhibition of rat and human glutathione S-transferase isoenzymes by disulfiram and diethyldithiocarbamate.

J P Ploemen1, M L van Iersel, L W Wormhoudt, J N Commandeur, N P Vermeulen, P J van Bladeren.   

Abstract

The drug disulfiram (DSF, Antabuse) has been used in the therapy of alcohol abuse. It is a potent inhibitor of aldehyde dehydrogenase. Its reduced form, diethyldithiocarbamate (DDTC), and further metabolites show similar activities. DSF and DDTC have also been widely used to inhibit mixed-function oxidases. In this study, the reversible inhibition and time-dependent inactivation of the major rat and human glutathione S-transferase (GST) isoenzymes by DSF and DDTC was investigated. Reversible inhibition, using 1-chloro-2,4-dinitrobenzene as substrate for the GST alpha-, mu-, and pi-class, expressed as I50 (in microM), ranged from 5-18 (human A1-1), 43-57 (rat 4-4) and 66-83 (rat 1-1), for both DSF and DDTC. The I50 for rat GST theta, using 1,2-epoxy-3-(p-nitrophenoxy)-propane as substrate, was 350 microM for DDTC. The other GSTs were significantly less sensitive to inhibition. The major part of reversible inhibition by DSF was shown to be due to DDTC, formed rapidly upon reduction of DSF by the glutathione (GSH) present in the assay to measure GST activity. The oxidized GSH formed upon reduction of DSF might also have made a minor contribution to reversible inhibition. The rat and human pi-class was, by far, the most sensitive class for time-dependent inactivation by DSF, but no such inactivation was observed for any of the GSTs by DDTC. Moderate susceptibility to inactivation by DSF of all the other GSTs was observed, except for human A2-2, which does not possess a cysteine residue. Consistent with the assumption that a thiol residue is involved in this inactivation, a significant part of the activity could be restored by treatment of the inactivated GST with GSH or dithiotreitol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694843     DOI: 10.1016/0006-2952(96)00142-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.

Authors:  Matthew Pratt-Hyatt; Hsia-lien Lin; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2010-09-08       Impact factor: 3.922

2.  Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.

Authors:  Rhushikesh A Kulkarni; Stephanie M Stanford; Nadeem A Vellore; Divya Krishnamurthy; Matthew R Bliss; Riccardo Baron; Nunzio Bottini; Amy M Barrios
Journal:  ChemMedChem       Date:  2013-07-19       Impact factor: 3.466

3.  Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PLpro: insights from computational chemistry studies.

Authors:  Pablo Andrei Nogara; Folorunsho Bright Omage; Gustavo Roni Bolzan; Cássia Pereira Delgado; Laura Orian; João Batista Teixeira Rocha
Journal:  J Mol Model       Date:  2022-10-12       Impact factor: 2.172

4.  Vitamin B12b Enhances the Cytotoxicity of Diethyldithiocarbamate in a Synergistic Manner, Inducing the Paraptosis-Like Death of Human Larynx Carcinoma Cells.

Authors:  Marina Solovieva; Yuri Shatalin; Roman Fadeev; Olga Krestinina; Yulia Baburina; Alexey Kruglov; Ekaterina Kharechkina; Margarita Kobyakova; Vadim Rogachevsky; Elena Shishkova; And Vladimir Akatov
Journal:  Biomolecules       Date:  2020-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.